Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
5.98
-0.50 (-7.72%)
Mar 31, 2025, 1:29 PM EDT - Market open
Cogent Biosciences Employees
Cogent Biosciences had 205 employees as of December 31, 2024. The number of employees increased by 41 or 25.00% compared to the previous year.
Employees
205
Change (1Y)
41
Growth (1Y)
25.00%
Revenue / Employee
n/a
Profits / Employee
-$1,248,093
Market Cap
661.02M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 205 | 41 | 25.00% |
| Dec 31, 2023 | 164 | 26 | 18.84% |
| Dec 31, 2022 | 138 | 61 | 79.22% |
| Dec 31, 2021 | 77 | 62 | 413.33% |
| Dec 31, 2020 | 15 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
COGT News
- 5 days ago - Cogent Biosciences Announces Multiple Poster Presentations at 2025 American Association for Cancer Research (AACR) Annual Meeting - GlobeNewsWire
- 24 days ago - Cogent Biosciences Announces Participation in the Leerink Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Cogent Biosciences Announces SUMMIT Continues to Showcase Powerful Symptomatic Improvement in NonAdvanced Systemic Mastocytosis Patients - GlobeNewsWire
- 4 weeks ago - Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 7 weeks ago - Cogent Biosciences Announces Bezuclastinib Poster in NonAdvanced Systemic Mastocytosis (NonAdvSM) at the 2025 AAAAI Annual Meeting - GlobeNewsWire
- 2 months ago - 3 Biotech Stocks With Notable Insider Buying - Seeking Alpha
- 2 months ago - Cogent Biosciences: Buy The Pullback For Bezuclastinib's 2025 SM And GIST Data - Seeking Alpha
- 3 months ago - Why Is Cogent Biosciences Stock Trading Higher On Monday? - Benzinga